Author:
Guidelli G. M.,Fioravanti A.,Rubegni P.,Feci L.
Publisher
Springer Science and Business Media LLC
Subject
Immunology,Immunology and Allergy,Rheumatology
Reference15 articles.
1. Emery P, Fleischmann R, Filipowicz-Sosnowska A, Schechtman J, Szczepanski L, Kavanaugh A et al (2006) The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: results of a phase IIB randomized, double-blind, placebo-controlled, dose-ranging trial. Arthr Rheum 54:1390–1400
2. Lee YH, Bae SC, Song GG (2011) The efficacy and safety of rutuximab for the treatment of active rheumatoid arthritis: a systematic review and meta-analysis of randomized controlled trials. Rheumatol Int 31:1493–1499
3. Lowndes S, Darby A, Meal G, Lister A (2002) Stevens–johnson syndrome after treatment with rituximab. Ann Oncol 13:1948–1950
4. Markatseli TE, Kaltsonoudis ES, Voulgari PV, Zioga A, Drosos AA (2009) Induction of psoriatic skin lesions in a patient with rheumatoid arthritis treated with rituximab. Clin Exp Rheumatol 27:996–998
5. Dass S, Vital EM, Emery P (2007) Development of psoriasis after B cell depletion with rituximab. Arthr Rheum 56:2715–2718
Cited by
45 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献